CHAF1B knockdown blocks migration in a hepatocellular carcinoma model

Area of Science:

• Molecular Biology
• Oncology
• Gene Expression Analysis

Background:

• The precise roles of Chromatin Assembly Factor-1B (CHAF1B) in liver cancer remain unclear.
• Understanding CHAF1B's function is crucial for developing targeted therapies for hepatocellular carcinoma.

Purpose of the Study:

• To investigate the function and mechanism of CHAF1B in liver cancer.
• To assess the impact of CHAF1B knockdown on hepatocellular carcinoma cell behavior and tumor growth.

Main Methods:

• CHAF1B gene knockdown in HUH-7 hepatocellular carcinoma cells using lentivirus.
• Assays for cell migration, invasion, and cell cycle analysis (scratch wound healing, Transwell, flow cytometry).
• Gene expression profiling, Western blot, and RT-PCR to analyze gene and protein level changes.
• In vivo tumor growth studies in mouse models.

Main Results:

• CHAF1B knockdown significantly reduced HUH-7 cell invasion and migration.
• Gene expression profiling identified significant changes in PSMB6, SLC30A7, SMC3, TWF2, and BLM post-knockdown.
• CHAF1B knockdown led to cell cycle alterations, with fewer G0/G1 phase cells and more S phase cells.
• Tumor growth was significantly inhibited in CHAF1B-knockdown models compared to controls.

Conclusions:

• CHAF1B plays a significant role in promoting liver cancer cell invasion, migration, and tumor growth.
• Downregulation of CHAF1B impacts cell cycle progression and alters the expression of key genes involved in cancer progression.
• Targeting CHAF1B presents a potential therapeutic strategy for hepatocellular carcinoma.